# Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass

> **NCT02775123** · PHASE1,PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 30 (actual)

## Conditions studied

- Myocardial Ischemia
- Heart Valve Diseases

## Interventions

- **DEVICE:** Cytosorb

## Key facts

- **NCT ID:** NCT02775123
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02775123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02775123, "Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02775123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*